- Home
- HQI vs CMPX Comparison
HQI vs CMPX Comparison
Compare HQI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- CMPX
- Stock Information
- Founded
- HQI 2002
- CMPX 2014
- Country
- HQI United States
- CMPX United States
- Employees
- HQI N/A
- CMPX N/A
- Industry
- HQI Professional Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- HQI Consumer Discretionary
- CMPX Health Care
- Exchange
- HQI Nasdaq
- CMPX Nasdaq
- Market Cap
- HQI 143.3M
- CMPX 291.8M
- IPO Year
- HQI N/A
- CMPX N/A
- Fundamental
- Price
- HQI $9.82
- CMPX $2.97
- Analyst Decision
- HQI Strong Buy
- CMPX Strong Buy
- Analyst Count
- HQI 2
- CMPX 9
- Target Price
- HQI $16.00
- CMPX $12.67
- AVG Volume (30 Days)
- HQI 14.9K
- CMPX 839.1K
- Earning Date
- HQI 08-07-2025
- CMPX 08-11-2025
- Dividend Yield
- HQI 2.49%
- CMPX N/A
- EPS Growth
- HQI N/A
- CMPX N/A
- EPS
- HQI 0.24
- CMPX N/A
- Revenue
- HQI $33,651,000.00
- CMPX $850,000.00
- Revenue This Year
- HQI N/A
- CMPX N/A
- Revenue Next Year
- HQI $4.99
- CMPX N/A
- P/E Ratio
- HQI $39.80
- CMPX N/A
- Revenue Growth
- HQI N/A
- CMPX N/A
- 52 Week Low
- HQI $9.04
- CMPX $0.87
- 52 Week High
- HQI $15.75
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- HQI 48.58
- CMPX 66.60
- Support Level
- HQI $10.20
- CMPX $2.64
- Resistance Level
- HQI $10.41
- CMPX $3.00
- Average True Range (ATR)
- HQI 0.19
- CMPX 0.18
- MACD
- HQI -0.01
- CMPX 0.02
- Stochastic Oscillator
- HQI 43.25
- CMPX 90.00
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.